XML 25 R13.htm IDEA: XBRL DOCUMENT v3.21.1
5) Stock Compensation Plans
 3 Months Ended
Mar. 31, 2021
Disclosure Text Block [Abstract]  
5) Stock-based Compensation

5)       Stock Compensation Plans

 

The Company has two fixed option plans (the “2013 Plan” and the “2014 Director Plan”). Compensation expense for options issued of $39,153 and $65,877 has been recognized for these plans for the three months ended March 31, 2021 and 2020, respectively. As of March 31, 2021, the total unrecognized compensation expense related to the options issued was $-0-.

 

The fair value of each option granted is estimated on the date of grant using the Black Scholes Option Pricing Model. The Company estimates the expected life of the options using the simplified method. Future volatility is estimated based upon the weighted historical volatility of the Company’s Class A common stock over a period equal to the expected life of the options. The risk-free interest rate for the expected life of the options is based upon the Federal Reserve Board’s daily interest rates in effect at the time of the grant.

 

A summary of the status of the Company’s stock compensation plans as of March 31, 2021, and the changes during the three months ended March 31, 2021, are presented below:

 

    Number of
Class A Shares		   Weighted Average Exercise Price   Number of
Class C Shares		   Weighted Average Exercise Price
                 
Outstanding at January 1, 2021   1,072,863    $ 4.33   662,666   $ 4.73
Adjustment for effect of stock dividends   -        -    
Granted   -        -    
Exercised   (32,925)       -    
Cancelled   -        -    
Outstanding at March 31, 2021   1,039,938    $ 4.34   662,666   $ 4.73
                 
As of March 31, 2021:                
Options exercisable   1,039,938    $ 4.34   662,666   $ 4.73
                 
As of March 31, 2021:                
Available options for future grant   330,371        266,500    
                 
Weighted average contractual term of options                
outstanding at March 31, 2021   6.28years       6.71years    
                 
Weighted average contractual term of options                
exercisable at March 31, 2021   6.28years       6.71years    
                 
Aggregated intrinsic value of options                
outstanding at March 31, 2021 (1)   $ 5,212,677        $ 3,059,620    
                 
Aggregated intrinsic value of options                
exercisable at March 31, 2021 (1)   $ 5,212,677        $ 3,059,620    

   

(1) The Company used a stock price of $9.35 as of March 31, 2021 to derive intrinsic value.

 

A summary of the status of the Company’s stock compensation plans as of March 31, 2020, and the changes during the three months ended March 31, 2020, are presented below:

 

    Number of
Class A Shares		   Weighted Average Exercise Price   Number of
Class C Shares		   Weighted Average Exercise Price
                 
Outstanding at January 1, 2020   1,086,053    $ 4.41   594,132   $ 5.36
Adjustment for effect of stock dividends   829        -    
Granted   37,500        90,000    
Exercised   (42,294)       -    
Cancelled   -        -    
Outstanding at March 31, 2020   1,082,088    $ 4.44   684,132   $ 5.15
                 
As of March 31, 2020:                
Options exercisable   985,366    $ 4.42   452,381   $ 5.39
                 
As of March 31, 2020:                
Available options for future grant   97,218        -    
                 
Weighted average contractual term of options                
outstanding at March 31, 2020   5.57years       5.96years    
                 
Weighted average contractual term of options                
exercisable at March 31, 2020   5.16years       4.70years    
                 
Aggregated intrinsic value of options                
outstanding at March 31, 2020 (1)   $ 489,237        $ 41,150    
                 
Aggregated intrinsic value of options                
exercisable at March 31, 2020 (1)   $ 471,642        $ -    

   

(1) The Company used a stock price of $4.27 as of March 31, 2020 to derive intrinsic value.

 

The total intrinsic value (which is the amount by which the fair value of the underlying stock exceeds the exercise price of an option on the exercise date) of stock options exercised during the three months March 31, 2021 and 2020 was $139,035 and $73,072, respectively.